Procter & Gamble Health

Mumbai, India Founded: 1967 • Age: 59 yrs Listed
Manufacturer of OTC, vitamin mineral supplements, and chemical products
Request Access
Report Incorrect Data
Page last updated

About Procter & Gamble Health

Procter & Gamble Health is a publicly listed company based in Mumbai (India) founded in 1967. Manufacturer of OTC, vitamin mineral supplements, and chemical products. The company has 1,560 employees. Its chief executive, as recorded, is L V Vaidyanathan. Its Indian entity Procter & Gamble Health Limited reported revenue of ₹1,585 Cr. Procter & Gamble Health offers products and services including Vitamins and Supplements. Its focus areas include Diversified Pharmaceuticals and Drugs.

Company details

Procter Gamble Health, established in 1967, excels in providing healthcare solutions, diversified pharmaceuticals, and drugs. Manufacturer of OTC, vitamin mineral supplements, and chemical products. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

  • Headquarters Mumbai, India
  • Employees 1,560
  • Stage Public
  • Sectors
    Healthcare
  • Website pghealthindia.com
  • Social LinkedIn
  • Legal Name Procter & Gamble Health Ltd.
Operational Areas
Healthcare → Pharmaceuticals & Distribution
Key Metrics
  • Market Cap
    ₹9,590 Cr

    PGHL · NSE

  • Share Price
    ₹5,779.50

    +0.03% today

  • Revenue
    ₹1,567 Cr

    FY 2025-26 · +52.3% YoY

  • EBITDA
    ₹457 Cr

    Margin 29.1%

  • Net Profit
    ₹328 Cr

    FY 2025-26 · +40.0% YoY

  • P/E (TTM)
    26.6x

    P/B 14.4x

  • ROE
    61.6%

    ROCE 76.9%

  • Debt / Equity
    0.02

    Interest cover 0.1x

  • Employee Count
    1,560

Products & Services of Procter & Gamble Health

Procter & Gamble Health offers a comprehensive portfolio of products and services, including Vitamins and Supplements.

Vitamins and Supplements
Health Products

Products that enhance daily health and lifestyle for consumers

Board of directors of Procter & Gamble Health Limited (Procter & Gamble Health)

Procter & Gamble Health Limited is the primary company behind Procter & Gamble Health. The board of Procter & Gamble Health Limited currently have 8 directors; the longest-serving is Milind Vasant Thatte, appointed in 2018. 35 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Milind Vasant Thatte
DIN 08092990
Managing Director01 Apr 20188 yrs 7 moProcter & Gamble Health Limited
Aalok Agrawal
DIN 08468145
Director01 Jun 20197 yrs 5 moProcter & Gamble Health Limited
Subramanian Madhavan
DIN 06451889
Director15 Nov 20214 yrs 11 moProcter & Gamble Health Limited
Seema Sambasivan
DIN 10085866
Director01 Apr 20233 yrs 7 moProcter & Gamble Health Limited
Lokesh Chandak
DIN 10083315
CFO01 Apr 20233 yrs 7 moProcter & Gamble Health Limited
Sharad Tyagi
DIN 00371842
Director01 Apr 20251 yr 7 moProcter & Gamble Health Limited
Krishna Sarma
DIN 00016115
Director01 Apr 20251 yr 7 moProcter & Gamble Health Limited
Shashank Raghupathy Srowthy
DIN 11317956
Whole-time director01 Oct 20251 yr 1 moProcter & Gamble Health Limited

People of Procter & Gamble Health

1263 people are tracked at Procter & Gamble Health (786 in leadership, 11 in board & advisors, 466 in team); the tracked headcount is 1,560.

NameRoleGroup
L V Vaidyanathan
CEOLeadership
Eldon Cate
Media DirectorLeadership
Gianluca Branda
Vice President -europe Fabric Care Product SupplyLeadership
Chad Wehrman - Cfe
Global Security Director - Na/global Governance And OperationsLeadership
Emma Pretswell
Vice President Quality AssuranceLeadership
Angarish Otta
Director, ITLeadership
Ping Hu
R&d Director Principal ScientistLeadership
Jessi Capone
Bounty Initiatives Engineering DirectorLeadership
Christine Chia
Brand Director, Sk-ii Super PremiumLeadership
Beatrice Tessier
Brand Director Personal Care EuropeLeadership
Marcello Puddu
R&d Senior Director New Product Platform And Pilot Plant Operations Fabric CareLeadership
Jeff Morris
Finance Director, Northeast Region Customer TeamLeadership
Ranya Shamoon
Senior Vice-president, Baby Care Category Growth & TransformationLeadership
Valérie le Bris
Human Resources DirectorLeadership
Doug Melton
Vice President Global R&d/supply Chain - Breakthrough Product InnovationLeadership
Emma Adelman
Product Management Director - NA Grooming Retail OperationsLeadership
Yoshiaki Kondo
Brand Director - Dish Care Design, Fabric&home Care Growthworks InnovationLeadership
Nick Montesano
Director, Walmart Category Management And AdvisoryLeadership
Baptiste Pommiers
R&d Director - Global Product Stewardship - France & BeneluxLeadership
Stephanie Osborn
Senior Brand DirectorLeadership

1243 more people are available in the full profile.

Premium access

Complete people profiles for Procter & Gamble Health

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Procter & Gamble Health

Procter & Gamble Health is a publicly listed company on the NSE with ticker symbol PGHL in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date24 Apr 1996
  • Listed onNSE: PGHL
  • Listed entityProcter & Gamble Health Ltd.
  • Exchange sectorHealth technology
  • ISININE199A01012
  • Share price₹5,245.00 (-0.95% on the day) · 2026-10-14
  • Market capitalisation₹8,753 Cr
  • Price to earnings26.6
  • EPS (diluted, trailing year)₹196.94
  • Dividend yield2.98%
  • Volume (last session)3,215

Financials of Procter & Gamble Health

Exchange-reported figures of Procter & Gamble Health Limited, the listed company behind Procter & Gamble Health (NSE: PGHL).

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹1,567 Cr
+52.3% YoY
EBITDA
₹457 Cr
+43.4% YoY
Profit After Tax
₹328 Cr
+40.0% YoY
Net Worth
₹525 Cr
-2.3% YoY
Total Assets
₹590 Cr
+1.4% YoY
Total Debt
₹9.29 Cr
+21.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income statement
Revenue1,5671,0291,1511,2301,1141,0091,356
Revenue growth+52.3%--6.4%+10.3%+10.5%-25.6%-
EBITDA457318286325268246315
EBITDA margin+29.1%+30.9%+24.8%+26.4%+24.0%+24.4%+23.3%
Profit before tax450312273314253233355
Net profit328235216229193177256
Net profit margin+21.0%+22.8%+18.7%+18.6%+17.3%+17.6%+18.9%
EPS (₹)196.93188.28121.07138.23115.98106.51102.04
Balance sheet
Total assets590582-----
Net worth525537-----
Total debt9.297.62-----
Cash & bank185189-----
Net working capital305314-----
Cash flow
Cash from operations338169-----
Cash from investing1.269.59-----
Cash from financing(344)(235)-----
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue382364370374325339311310
Revenue growth (YoY)+17.7%+7.4%+19.1%+20.7%+3.7%+19.3%--
Other income3.8935.684.004.364.954.033.113.96
Total expenses230264235263205248230186
EBITDA15299.6013611012090.3480.92123
EBITDA margin+39.8%+27.4%+36.6%+29.5%+37.0%+26.7%+26.0%+39.8%
Depreciation6.086.026.175.906.085.445.375.55
Interest0.130.140.210.100.120.120.130.15
Profit before tax15012913310911988.8178.53122
Tax38.5432.9738.6131.2330.4822.6317.3530.79

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 12 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue382364370374325339311310
Revenue growth (YoY)+17.7%+7.4%+19.1%+20.7%+3.7%+19.3%--
Other income3.8935.684.004.364.954.033.113.96
Total expenses230264235263205248230186
EBITDA15299.6013611012090.3480.92123
EBITDA margin+39.8%+27.4%+36.6%+29.5%+37.0%+26.7%+26.0%+39.8%
Depreciation6.086.026.175.906.085.445.375.55
Interest0.130.140.210.100.120.120.130.15
Profit before tax15012913310911988.8178.53122
Tax38.5432.9738.6131.2330.4822.6317.3530.79
ParticularsFY 2025-26FY 2024-25Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Revenue1,5671,0291,1511,2301,1141,0091,356
Revenue growth+52.3%--6.4%+10.3%+10.5%-25.6%-
Other income17.3410.3515.6318.3913.1918.1068.89
Total expenses1,1117118659058477631,040
Employee cost223142215206168154183
EBITDA457318286325268246315
EBITDA margin+29.1%+30.9%+24.8%+26.4%+24.0%+24.4%+23.3%
Depreciation23.5916.6927.4028.1027.0830.0429.45
Interest0.550.430.720.770.420.800.00
Profit before tax450312273314253233355
Tax12377.2172.3484.7360.8556.48101
Net profit328235216229193177256
Net profit margin+21.0%+22.8%+18.7%+18.6%+17.3%+17.6%+18.9%
EPS (₹)196.93188.28121.07138.23115.98106.51102.04
ParticularsFY 2025-26FY 2024-25Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Equity & liabilities
Share capital16.6016.60-----
Reserves & surplus508520-----
Shareholders' funds (net worth)525537-----
Secured loans0.000.00-----
Unsecured loans9.297.62-----
Total debt9.297.62-----
Total liabilities590582-----
Assets
Gross block236232-----
Net block102116-----
Capital work in progress13.5910.96-----
Investments0.000.00-----
Inventories137109-----
Sundry debtors164145-----
Cash & bank balances185189-----
Loans & advances70.0683.07-----
Total current assets556526-----
Total current liabilities251212-----
Net working capital305314-----
Total assets590582-----
ParticularsFY 2025-26FY 2024-25Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Opening cash182239-----
Net cash from operating activities338169-----
Net cash from investing activities1.269.59-----
Net cash from financing activities(344)(235)-----
Net change in cash(4.87)(56.46)-----
Closing cash185189-----
ParticularsFY 2025-26FY 2024-25Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Growth
Sales growth+52.3%--6.4%+10.3%+10.5%-25.6%-
EBITDA growth+43.4%--12.0%+21.3%+8.8%-22.0%-
PBT growth+8.3%+52.0%-13.0%+24.0%+8.6%-1.4%-73.6%
Net income growth+40.0%--5.8%+18.7%+8.9%-30.9%-
Revenue CAGR (3Y)+9.2%-2.9%+4.5%-3.2%+8.1%+11.1%+9.3%
EBITDA CAGR (3Y)+13.2%+6.5%+5.1%+1.0%+18.4%+39.4%+33.2%
Profitability & leverage
Net income margin+20.9%+22.8%+17.5%+18.7%+17.3%+17.5%+18.7%
Return on capital employed+76.9%+71.8%+39.8%+43.2%+36.0%+27.5%+18.8%
Return on net worth+61.6%+58.1%+31.2%+33.6%+29.2%+22.0%+13.9%
Debt / equity0.020.020.020.010.010.000.00
Long-term debt / equity0.010.010.010.010.000.000.00
Interest cover0.130.140.280.260.170.370.00
Efficiency & per share
Fixed asset turnover6.695.964.634.784.784.754.57
Inventory turnover12.7412.569.439.839.547.997.31
Debtors turnover10.1211.8911.4512.3515.5613.0111.20
EPS (₹)196.93188.28121.07138.23115.98106.51102.04
Dividend per share (₹)205.00125.00260.0095.0052.50130.00230.00
Book value per share (₹)315.99323.47324.24452.34371.38423.92545.99

Web traffic of Procter & Gamble Health

The website of Procter & Gamble Health (pghealthindia.com) receives about 8.9K visits a month.

  • Monthly visits
    8.9K

    ▲ 114.6% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Procter & Gamble Health

PGHL: Q2 SL NET PROFIT 1.15B RUPEES VS 885.4M (YOY)
Exchange Update • 10 days ago
PGHL: Q2 EBITDA 1.52B RUPEES VS 1.2B (YOY); Q2 EBITDA MARGIN 39.84% VS 37.02% (YOY)
Exchange Update • 10 days ago
Procter & Gamble Health Says June-Quarter Net Profit 961.5 Million Rupees
Reuters • 3 months ago
Procter & Gamble Health standalone net profit rises 45.29% in the June 2026 quarter | Capital Market News - Business Standard
Business Standard • 3 months ago
Procter & Gamble Health Dec-Quarter Net Profit 775.9 Million Rupees
Reuters • 9 months ago
When crypto prices tumbled, what of the corporate hoarders?
Reuters • 11 months ago
Wall Street indexes try to turn around their frowns
Reuters • 11 months ago
Procter & Gamble Health Sept-Quarter Net Profit 885.4 Million Rupees
Reuters • 1 year ago
Procter & Gamble Health Appoints Shashank Srowthy As CFO
Reuters • 1 year ago
Procter & Gamble Health appoints Shashank Srowthy as CFO - The Economic Times
Economic Times • 1 year ago
Premium access

Complete news archive for Procter Gamble Health

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Procter & Gamble Health

Procter & Gamble Health was founded in 1967.

Procter & Gamble Health is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

L V Vaidyanathan is the CEO of Procter & Gamble Health, as recorded in our data.

Procter & Gamble Health has 1,560 employees.

The primary company behind Procter & Gamble Health, Procter & Gamble Health Limited, reported revenue of ₹1,585 Cr for FY 2026, up 14% year on year.

Procter Gamble Health, established in 1967, excels in providing healthcare solutions, diversified pharmaceuticals, and drugs. Manufacturer of OTC, vitamin mineral supplements, and chemical products. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Procter & Gamble Health offers Vitamins and Supplements.

Yes, Procter & Gamble Health is publicly traded on NSE under the ticker symbol PGHL.

Procter & Gamble Health operates through Procter & Gamble Health Limited.

The legal entities of Procter & Gamble Health currently have 9 directors, including Sharad Tyagi, Zeal Jayesh Shah, Krishna Sarma and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available